Literature DB >> 18860765

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.

S FARBER, L K DIAMOND.   

Abstract

Entities:  

Keywords:  FOLIC ACID/antagonist; LEUKEMIA

Mesh：

Substances：

Year:  1948        PMID： 18860765     DOI： 10.1056/NEJM194806032382301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  274 in total

Review 1.  Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Authors:  J Lilleyman
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Current status of cancer chemotherapy.

Authors:  M C LI
Journal:  J Natl Med Assoc       Date:  1960-09       Impact factor: 1.798

3.  The problem of therapy in acute leukaemia.

Authors:  A P MULLICK
Journal:  Indian J Pediatr       Date:  1957-09       Impact factor: 1.967

4.  Chemical and biological studies on 1, 2-dihydro-s-triazines. VII. Activity in pteroylglutamic acid-Lactobacillus casei #7469 systems.

Authors:  G E FOLEY; E C HALEY
Journal:  Antonie Van Leeuwenhoek       Date:  1955       Impact factor: 2.271

5.  [Treatment of polycythemia vera with daraprim].

Authors:  H KLEINFELDER; H BRACHARZ
Journal:  Klin Wochenschr       Date:  1956-05-15

6.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

Review 7.  Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948.

Authors:  Peter D Spain; Nina Kadan-Lottick
Journal:  J R Soc Med       Date:  2012-04       Impact factor: 5.344

Review 8.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

9.  A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor.

Authors:  N S Stuart; S M Crawford; G R Blackledge; E S Newlands; J Slack; R Hoffman; M F Stevens
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 10.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.